Schroder European Alpha Plus A Acc

Ranked 120 out of 127 in - Europe Excluding UK over 12 months
All calculations are in GBP unless stated

Managed by

James Sym

James Sym joined Cazenove Capital in 2007. He is a member of the pan-European equity team with responsibility for Chemicals, Support Services, Household Goods, Personal Goods, Pharmaceuticals & Biotechnology and Telecommunication sector coverage. James manages the Schroder European Alpha and Alpha Plus funds. He graduated from St John's College, Cambridge University with a degree in Natural Sciences (Mineral Physics) and Management Studies and is a Chartered Financial Analyst. He has six years of investment experience.

Objective

The Fund aims to provide capital growth by investing in equity and equity related securities of European companies, excluding the UK. The Fund invests at least 80% of its assets in a concentrated range of equity and equity related securities of European countries, excluding the UK. The Fund typically holds 35 to 60 companies.

Showing fund performance in United Kingdom View performance globally

Performance

Europe Excluding UK over : 31/05/2018 - 31/05/2019

Total Return

Quarterly Performance

to 31/03/2019 Annual Q1 Q2 Q3 Q4
2019 6.4%
2018 -17.4% -4.7% 3.7% -1.7% -15.0%
2017 19.1% 4.9% 7.1% 5.2% 0.8%
2016 24.4% -0.8% 2.9% 10.6% 10.2%
2015 11.6% 15.0% -2.2% -6.6% 6.3%
2014 -11.3% -1.0% -2.4% -4.5% -4.0%
2013 19.5% 11.6% -1.3% 2.3% 6.0%
2012 21.3% 11.5% -7.0% 11.2% 5.1%
2011 -14.2% 3.9% 2.3% -20.9% 2.1%
2010 13.6% 7.1% -12.0% 13.0% 6.7%
2009 18.2% -11.2% 8.7% 22.3% 0.2%
2008 -20.6% -4.8% -4.7% -10.3% -2.4%
2007 7.8% 4.8% 2.2% 0.0% 0.6%
2006 29.6% 16.4% -3.1% 5.0% 9.4%
2005 20.9% 3.0% 2.6% 8.1% 5.9%
2004 25.5% 3.4% 6.3% 3.5% 10.4%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

30/04/2019

Top 10 Holdings

Stock Size
Roche Holding AG Par 6.45%
AXA SA ORD 4.63%
Koninklijke KPN NV ORD 4.33%
Novo Nordisk A/S ORD 4.07%
Aurelius Equity Opportunities SE & Co KGaA ORD 4.05%
Grupo Catalana Occidente SA ORD 3.73%
KBC Groep NV ORD 3.60%
Sanofi SA ORD 3.24%
Zurich Insurance Group AG ORD 3.21%
Bankinter SA ORD 3.20%
30/04/2019

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date03/10/2003
  • Share Class size54Mn
  • Base currencyGBP
  • ISIN GB0033302877

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment50

Charges

  • Annual management1.50%
  • Initial investment0.00%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).